Switching, combination, dosing options and future directions in migraine treatment
Dr. Pablo Irimia (Clinic University of Navarra, Pamplona, Spain) discusses topics from the 7th congress of the European Academy of Neurology, including combination and switching between treatments, patient adherence, and the next great development in migraine research.
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now